Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000308622 | SCV000352469 | likely benign | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000367943 | SCV000352470 | likely benign | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000273876 | SCV000352471 | likely benign | Basal laminar drusen | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000333684 | SCV000352472 | likely benign | Age related macular degeneration 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Eurofins Ntd Llc |
RCV000735110 | SCV000863309 | likely benign | not specified | 2018-09-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000972577 | SCV001120298 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000972577 | SCV001147568 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | CFH: BP4, BS2 |
Gene |
RCV000972577 | SCV001802414 | uncertain significance | not provided | 2020-02-17 | criteria provided, single submitter | clinical testing | Reported in multiple individuals with atypical hemolytic uremic syndrome or age-related macular degeneration (Neumann et al., 2003; Caprioli et al., 2003; Maga et al., 2010; Sartz et al., 2012; van de Ven et al., 2013; Duvvari et al., 2016; Szarvas et al., 2016; Besbas et al., 2017; Seaby et al., 2017; Fidalgo et al., 2017; Gaut et al., 2017; Geerlings et al., 2018); Functional studies demonstrated moderately decreased cofactor function of factor H and somewhat decreased expression, but normal complement inhibitory function in fluid phase (Mohlin et al., 2015); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32424742, 31118930, 31865800, 30870849, 26826462, 23251215, 25733390, 29888403, 30046676, 30377230, 28589114, 29148534, 28056875, 26346198, 27007659, 23685748, 12960213, 22250080, 23660864, 18557729, 28752844, 20513133, 14583443) |
Genome Diagnostics Laboratory, |
RCV002294234 | SCV002587675 | likely benign | Atypical hemolytic-uremic syndrome | 2021-01-04 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000735110 | SCV004025200 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000972577 | SCV002034030 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000972577 | SCV002035024 | likely benign | not provided | no assertion criteria provided | clinical testing |